Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel

British Journal of Dermatology

Volumn 163, Issue 6, 2010, Pages 1357-1358

  Nakamura, Y ^a,a   Hori, E ^a   Furuta, J ^a   Kawachi, Y ^a   Otsuka, F ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

angiosarcoma; docetaxel; paclitaxel; taxanes

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; DOCETAXEL;

AGED; ANGIOSARCOMA; CANCER CHEMOTHERAPY; CANCER SIZE; CASE REPORT; CELL INFILTRATION; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DEPIGMENTATION; DRUG WITHDRAWAL; ENDOTHELIUM CELL; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; OUTPATIENT CARE; PATIENT DECISION MAKING; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCALP TUMOR; SKIN BIOPSY; SKIN BLEEDING; SKIN DEFECT; SKIN PIGMENTATION; SKIN ULCER; TREATMENT REFUSAL; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS; BIOPSY; FEMALE; HEAD AND NECK NEOPLASMS; HEMANGIOSARCOMA; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; SCALP; SKIN NEOPLASMS; TAXOIDS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 78649674122     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10000.x     Document Type: Letter

References (10)

1. Pawlik TM, Paulino AF, McGinn CJ, et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer 2003; 98: 1716-26.
2. Itakura E, Yamamoto H, Oda Y, et al. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J Surg Oncol 2008; 97: 74-81.
3. Abraham JA, Hornicek FJ, Kaufman AM, et al. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 2007; 14: 1953-67.
4. Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999; 86: 2034-7.
5. Verweij J, Lee SM, Ruka W, et al. Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma group. J Clin Oncol 2000; 18: 2081-6.
6. Isogai R, Kawada A, Aragane Y, et al. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel. J Dermatol 2004; 31: 335-41.
7. Veliz M, Chang V, Kasimis B, et al. Durable response of angiosarcoma of the face and scalp to docetaxel. Clin Oncol (R Coll Radiol) 2007; 19: 210.
8. Nagano T, Yamada Y, Ikeda T, et al. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer 2007; 110: 648-51.
9. Edmonson JH, Ebbert LP, Nascimento AG, et al. Phase II study of docetaxel in advanced soft tissue sarcomas. Am J Clin Oncol 1996; 19: 574-6.
10. Penel N, Lansiaux A, Adenis A,. Angiosarcomas and taxanes. Curr Treat Options Oncol 2007; 8: 428-34.